This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Using data from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS), Dr. Qiao-Li Wang and colleagues recently set out to further characterize the association between ...

FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced longer-term efficacy and safety results from Arm ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...

WASHINGTON, D.C. — It is known that men who have a family history of prostate cancer (PCa) are at increased risk of the malignancy, but a new study shows that a family history of other cancers in ...

Among individuals with gastroesophageal reflux disease (GERD), a negative upper endoscopy is associated with decreased risk in incidence and mortality from gastrointestinal cancer. The benefit ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and the University of Oxford today announced that results from the ...

We’re calling for clinical research proposals tackling unmet needs in four upper gastrointestinal (GI) cancers: pancreatic, liver, oesophageal and gastric cancer. Funding is available through the ...